Table 4 Functional annotation of 22 variants associated with lung cancer risk with strong evidence using HaploReg v4.1 and PolyPhen-2.

From: Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies

variant

Gene (or near gene)ǁ

HaploReg v4.1

PolyPhen-2§

GERP conserved

Promoter histone marks

Enhancer histone marks

DNAse

Proteins bound

Motifs changed

NHGRI/EBI GWAS hits

GRASP QTL hits

Selected eQTL hits

RefSeq genes

dbSNP functional annotation

predicted consequence on protein function

PolyPhenscore

rs1760944

APEX1

 

24 tissues*

14 tissues*

52 tissues*

11 bound proteins

  

2 hits

69 hits*

OSGEP

5′UTR

  

rs6495309

CHRNA3

 

THYM

4 tissues

THYM

 

7 altered

 

2 hits

10 hits

1.4 kb 3′ of CHRNB4

   

rs1126579

CXCR2

 

BLD

BLD

  

9 altered

  

69 hits*

CXCR2

3′UTR

  

rs6413432

CYP2E1

 

4 tissues

IPSC

  

8 altered

  

1 hit

CYP2E1

intronic

  

rs931794

HYKK

  

ESDR, SKIN, BRN

  

4 altered

 

1 hit

26 hits

AGPHD1

intronic

  

rs664677

ATM

  

BLD, FAT, LIV

  

4 altered

  

24 hits

ATM

intronic

  

rs402710

CLPTM1L

 

4 tissues

7 tissues

  

5 altered

1 hit

1 hit

1 hit

CLPTM1L

intronic

  

rs4646903

CYP1A1

 

SKIN

LNG

     

8 hits

241 bp 3′ of CYP1A1

   

rs2240308

AXIN2

 

22 tissues*

23 tissues*

6 tissues

 

Smad3

 

2 hits

3 hits

AXIN2

missense

benign

0

rs662

PON1

conserved

LNG*

10 tissues*

    

2 hits

2 hits

PON1

missense

benign

0

rs462779

REV3L

conserved

    

BRCA1, Nkx3

 

1 hit

2 hits

REV3L

missense

benign

0

rs1130409

APEX1

 

20 tissues*

23 tissues*

4 tissues

 

ZNF263

  

8 hits

APEX1

missense

benign

0

rs16969968

CHRNA5

        

32 hits*

CHRNA5

missense

benign

0.045

rs13181

ERCC2

conserved

ESDR, SKIN, SPLN

4 tissues

4 tissues

  

1 hit

3 hits

18 hits*

ERCC2

missense

benign

0

rs4880

SOD2

 

24 tissues*

19 tissues*

46 tissues*

CMYC,POL2, SIN3AK20

CHD2

 

1 hit

29 hits*

SOD2

missense

benign

0

rs351855

FGFR4

conserved

4 tissues

15 tissues*

LIV

 

5 altered

 

2 hits

15 hits

FGFR4

missense

probably damaging

0.998

rs1052133

OGG1

conserved

BLD, SKIN

10 tissues*

  

GATA

  

5 hits*

OGG1

missense

benign

0.121

rs1042522

TP53

 

5 tissues

9 tissues*

LNG*

 

9 altered

 

1 hit

1 hit

TP53

missense

benign

0.083

rs2736098

TERT

 

10 tissues*

16 tissues*

BLD

 

9 altered

1 hit

 

1 hit*

TERT

synonymous

  

rs11615

ERCC1

conserved

9 tissues

21 tissues*

4 tissues

ZNF263

EBF,Mtf1

 

2 hits

5 hits

ERCC1

synonymous

  

rs2910164

MIR146A

conserved

4 tissues

8 tissues

      

MIR146A

   

rs11614913

MIR196A2

conserved

13 tissues

16 tissues*

8 tissues*

 

HMG-IY

 

1 hit

6 hits

MIR196A2

   
  1. ǁThe gene name for the SNP, locating in a respective gene, was based on the annotation of dbSNP database (https://www.ncbi.nlm.nih.gov/snp/). The near gene name for a SNP that didn’t map into a gene region but its location nearby a gene based on the annotation of dbSNP database, and we also used this nearby gene name for the SNP in our study. HaploReg v4.1: a Web server for annotation of transcription regulation for genetic variants (http://archive.broadinstitute.org/mammals/haploreg/haploreg.php). §PolyPhen-2: a Web server for annotation of potential effects on protein structure and function for non-synonymous SNPs (http://genetics.bwh.harvard.edu/pph2/). The PolyPhen-2 reported a score that the calculated naive Bayes posterior probability of a given mutation being damaging ranging from 0 to 1, which was also classified as benign [0, 0.15], possibly damaging (0.15, 0.85], and probably damaging (0.85, 1], respectively. *Including regulatory evidence in lung cancer cell lines/tissues or normal lung cell lines/tissues. GWAS for the trait of lung cancer with a P-value at 4.0 × 10−6. GWAS for the trait of lung cancer with a P-value at 9.0 × 10−7.